,"This is a citation overview for a set of 298 documents.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 53 (Of the 298 documents considered for the h-Index, 53 have been cited at least 53 times.)",,,,,,,,,,,
,Note: Scopus does not have complete citation information for articles published before 1996.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,6584,1294,1397,2691,865,10140
2009,"Defining the Intensity of Conditioning Regimens: Working Definitions","Bacigalupo A., Sandmaier B.M., Barrett J., Blaise D., Lowski R., Horowitz M., Ballen K., Rizzo D., Giralt S., Lazarus H., Ho V., Apperley J., Slavin S., Pasquini M.",10838791,"Biology of Blood and Marrow Transplantation",, ,0,0,0,0,0,0
2009,"The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib","Khorashad J.S., Gerrard G., Loaiza S., Davis J., Goldman J., Melo J., Apperley J., Foroni L., Wagner S., Greener L., Marin D., Reid A., Milojkovic D., Patel H., Willimott S., Rezvani K.",03906078,"Haematologica",94, 6,0,0,0,0,0,0
2009,"Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation","Cordonnier C., Yakouben K., Pauksens K., Einsele H., Niederwieser D., Apperley J., Ljungman P., Labopin M., Chesnel V., Ribaud P., De La Camara R., Martino R., Ullmann A.J., Parkkali T., Locasciulli A.",10584838,"Clinical Infectious Diseases",48, 10,0,0,0,0,0,0
2009,"Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study","Ciceri F., Peccatori J., Pescarollo A., Magnani Z., Perna S.K., Crippa F., Callegaro L., Crocchiolo R., Bonini C., Fleischhauer K., Ponzoni M., Rossini S., Apperley J., Olavarria E., Ganser A., Fassas A., Anagnostopoulos A., Bregni M., Bruzzi P., Bordignon C., Bondanza A., Colombi S., Bernardi M.",14702045,"The Lancet Oncology",10, 5,0,0,0,0,3,3
2009,"Does a rise in the BCR-ABL1 transcript level identify chronic phase CML patients responding to imatinib who have a high risk of cytogenetic relapse?","Marin D., Apperley J.F., Khorashad J.S., Foroni L., Milojkovic D., Szydlo R., Reid A.G., Rezvani K., Bua M., Goldman J.M.",00071048,"British Journal of Haematology",145, 3,0,0,0,0,2,2
2009,"Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics","Reid A.G., De Melo V.A., Elderfield K., Clark I., Marin D., Apperley J., Naresh K.N.",01452126,"Leukemia Research",33, 3,0,0,0,0,0,0
2009,"The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies","Gratwohl A., Baldomero H., Schwendener A., Rocha V., Apperley J., Frauendorfer K., Niederwieser D.",02683369,"Bone Marrow Transplantation",43, 4,0,0,0,0,3,3
2009,"Severe events in donors after allogeneic hematopoietic stem cell donation","Halter J., Gratwohl A., Kodera Y., Ispizua A.U., Greinix H.T., Schmitz N., Favre G., Baldomero H., Niederwieser D., Apperley J.F.",03906078,"Haematologica",94, 1,0,0,0,0,0,0
2009,"The molecular anatomy of the FIP1L1-PDGFRA fusion gene","Walz C., Hochhaus A., Baccarani M., Grimwade D., Preudhomme C., Apperley J., Martinelli G., Saglio G., Cross N.C.P., Reiter A., Score J., Mix J., Cilloni D., Roche-Lestienne C., Yeh R.-F., Wiemels J.L., Ottaviani E., Erben P.",08876924,"Leukemia",23, 2,0,0,0,0,0,0
2008,"European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor","Marin D., Dazzi F., Pavlu J., Klammer M., Kaeda J.S., Goldman J.M., Apperley J.F., Milojkovic D., Olavarria E., Khorashad J.S., De Lavallade H., Reid A.G., Foroni L., Rezvani K., Bua M.",00064971,"Blood",112, 12,0,0,0,0,11,11
2008,"Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling.","Iacobelli S., Apperley J., Morris C.",0301472X,"Experimental hematology",36, 11,0,0,0,0,1,1
2008,"Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling","Iacobelli S., Apperley J., Morris C.",0301472X,"Experimental Hematology",36, 11,0,0,0,0,0,0
2008,"Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression","Khorashad J.S., Goldman J.M., Marin D., De Lavallade H., Apperley J.F., Milojkovic D., Reid A.G., Bua M., Szydlo R., Olavarria E., Kaeda J.",0732183X,"Journal of Clinical Oncology",26, 29,0,0,1,1,9,10
2008,"A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease","Flowers M.E.D., Michallet M., Prince H.M., Knobler R., Parenti D., Gallo J., Greinix H.T., Apperley J.F., Van Besien K., Elmaagacli A., Grigg A., Reddy V., Bacigalupo A., Kolb H.-J., Bouzas L.",00064971,"Blood",112, 7,0,0,0,0,7,7
2008,"Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis","De Lavallade H., Goldman J.M., Marin D., Apperley J.F., Khorashad J.S., Milojkovic D., Reid A.G., Bua M., Szydlo R., Olavarria E., Kaeda J.",0732183X,"Journal of Clinical Oncology",26, 20,0,0,4,4,17,21
2008,"Association between BMI-1 expression, acute graft-versus-host disease, and outcome following allogeneic stem cell transplantation from HLA-identical siblings in chronic myeloid leukemia","Mohty M., Szydlo R.M., Yong A.S.M., Apperley J.F., Goldman J.M., Melo J.V.",00064971,"Blood",112, 5,0,0,0,0,1,1
2008,"Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant","Shaw B.E., Kazmi M.A., Littlewood T.J., Milligan D.W., Pagliuca A., Thomson K.J., Marks D.I., Russell N.H., Mufti G.J., Mackinnon S., Cavenagh J.D., Pearce R.M., Towlson K.E., Apperley J.F., Chakraverty R., Craddock C.F.",02683369,"Bone Marrow Transplantation",42, 12,0,0,0,0,1,1
2008,"Successful peripheral blood stem cell mobilization with granulocyte colony-stimulating factor in a patient with chronic myeloid leukemia achieving a complete cytogenetic remission with dasatinib after failing imatinib","Gabriel I., Chaidos A., Sorouri J., Dannie E., Davis J., Goldman J., Apperley J., Marin D.",08876924,"Leukemia",22, 8,0,0,0,0,1,1
2008,"Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis","Khorashad J.S., De Melo V.A., Fiegler H., Gerrard G., Marin D., Apperley J.F., Goldman J.M., Foroni L., Reid A.G.",08876924,"Leukemia",22, 9,0,0,0,0,0,0
2008,"Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis","Pai M., Jestice K., Glibetic M., Bansi D., Khan S.A., Kyriakou D., Rountas C., Thillainayagam A., Nicholls J.P., Jensen S., Apperley J.F., Zacharoulis D., Gordon M.Y., Habib N.A., Milicevic M.N., Helmy S., Jiao L.R., Levicar N., Tait P., Scott M., Marley S.B.",00029270,"American Journal of Gastroenterology",103, 8,0,0,0,0,4,4
2008,"A new rapid and sensitive assay for detecting the T315I BCR-ABL kinase domain mutation in chronic myeloid leukaemia","Khorashad J.S., Thelwell N., Milojkovic D., Marin D., Watson J.A., Goldman J.M., Apperley J.F., Foroni L., Reid A.G.",00219746,"Journal of Clinical Pathology",61, 7,0,0,0,0,0,0
2008,"Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib","Hochhaus A., Silver R.T., Niederwieser D., Stone R.M., Dombret H., Larson R.A., Roy L., Hughes T., Muller M.C., Ezzeddine R., Countouriotis A.M., Baccarani M., Kantarjian H.M., Deininger M., Apperley J.F., Lipton J.H., Goldberg S.L., Corm S., Shah N.P., Cervantes F.",08876924,"Leukemia",22, 6,0,0,4,4,16,20
2008,"Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis","De Lavallade H., Apperley J.F., Marin D., Punnialingam S., Milojkovic D., Bua M., Khorashad J.S., Gabriel I.H., Chaidos A., Olavarria E., Goldman J.M.",00071048,"British Journal of Haematology",141, 5,0,0,3,3,6,9
2008,"V? genes in chronic lymphocytic leukaemia: Highly skewed V gene segment usage with similar CDR3 sequences","Abusedra A., Joshi R., Bybee A., Apperley J.F., Wagner S.D.",08876924,"Leukemia",22, 5,0,0,0,0,1,1
2008,"Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib- sensitivetyrosine kinases","Heinrich M.C., Town A., McKinley A., Supple S.G., Seymour J., Di Scala L., Van Oosterom A., Herrmann R., Nikolova Z., McArthur G., Joensuu H., Demetri G.D., Corless C.L., Apperley J., Fletcher J.A., Soulieres D., Dirnhofer S., Harlow A.",10780432,"Clinical Cancer Research",14, 9,0,0,3,3,9,12
2008,"Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements","De Melo V.A.S., Milojkovic D., Marin D., Apperley J.F., Nacheva E.P., Reid A.G.",01654608,"Cancer Genetics and Cytogenetics",182, 2,0,0,0,0,2,2
2008,"The EBMT activity survey 2006 on hematopoietic stem cell transplantation: Focus on the use of cord blood products","Gratwohl A., Baldomero H., Frauendorfer K., Rocha V., Apperley J., Niederwieser D.",02683369,"Bone Marrow Transplantation",41, 8,0,0,6,6,13,19
2008,"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia","Le Coutre P., O'Brien S.G., Kuliczkowski K., Hochhaus A., Mahon F.-X., Saglio G., Gobbi M., Kwong Y.-L., Baccarani M., Hughes T., Martinelli G., Ottmann O.G., Radich J.P., Zheng M., Shou Y., Kantarjian H., Giles F., Kim D.-W., Cortes J., Gattermann N., Apperley J.F., Larson R.A., Abruzzese E.",00064971,"Blood",111, 4,0,0,24,24,17,41
2008,"In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib","Khorashad J.S., Olavarria E., Marin D., Goldman J.M., Apperley J.F., Kaeda J.S., Milojkovic D., Mehta P., Anand M., Ghorashian S., Reid A.G., De Melo V., Babb A., De Lavallade H.",00064971,"Blood",111, 4,0,0,5,5,4,9
2008,"A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease","Gabriel I., Apperley J., Bower M., Chaidos A., Gazzard B., Giles C., Kew A., Nelson M., Kanfer E.",02699370,"AIDS",22, 4,0,0,0,0,0,0
2008,"A simple FISH assay for the detection of 3q26 rearrangements in myeloid malignancy [5]","De Melo V., Vetter M., Mazzullo H., Howard J.D., Betts D.R., Nacheva E.P., Apperley J.F., Reid A.G.",08876924,"Leukemia",22, 2,0,0,0,0,2,2
2008,"Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease","Levicar N., Jensen S.L., Nicholls J.P., Apperley J.F., Gordon M.Y., Pai M., Habib N.A., Tait P., Jiao L.R., Marley S.B., Davis J., Dazzi F., Smadja C.",09607722,"Cell Proliferation",41, 1,0,0,2,2,2,4
2008,"State-of-the-art in the treatment of chronic myeloid leukaemia","Milojkovic D., Apperley J.",10408746,"Current Opinion in Oncology",20, 1,0,0,1,1,0,1
2007,"Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia","Olavarria E., Perz J.B., O'Shea D., Goldman J.M., Apperley J.F., Craddock C.F., Siddique S., Griffiths M.J., Avery S., Byrne J.L., Piper K.P., Lennard A.L., Pallan L., Arrazi J.M.",00064971,"Blood",110, 13,0,0,5,5,4,9
2007,"Part II: Management of resistance to imatinib in chronic myeloid leukaemia","Apperley J.F.",14702045,"Lancet Oncology",8, 12,0,0,4,4,7,11
2007,"Predictability of hematopoietic stem cell transplantation rates","Gratwohl A., Baldomero H., Schwendener A., Gratwohf M., Apperley J., Niederwieser D., Frauendorfer K.",03906078,"Haematologica",92, 12,0,0,0,0,4,4
2007,"Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression","Brazma D., Grace C., Howard J., Melo J.V., Holyoke T., Apperley J.F., Nacheva E.P.",10452257,"Genes Chromosomes and Cancer",46, 11,0,0,5,5,3,8
2007,"Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab","Perz J.B., Apperley J.F., Olavarria E., Szydlo R., Sergeant R., Sanz J., O'Shea D., Khan T., Davey N., Loaiza S., Davis J.",09663274,"Transplant Immunology",18, 2,0,0,1,1,0,1
2007,"Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia","Apperley J.F.",14702045,"Lancet Oncology",8, 11,0,0,15,15,32,47
2007,"Philadelphia-negative clonal hematopoiesis is a significant feature of dasatinib therapy for chronic myeloid leukemia [8]","De Melo V.A.S., Milojkovic D., Khorashad J.S., Marin D., Goldman J.M., Apperley J.F., Reid A.G.",00064971,"Blood",110, 8,0,1,1,2,2,4
2007,"Interferon-? or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation","De Lavallade H., Khorashad J.S., Davis H.P., Milojkovic D., Kaeda J.S., Goldman J.M., Apperley J.F., Marin D.",00064971,"Blood",110, 7,0,1,6,7,1,8
2007,"Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation","Perz J.B., Marin D., Szydlo R.M., Giles C., Olavarria E., Williams G., Apperley J.F.",01452126,"Leukemia Research",31, 10,0,0,1,1,0,1
2007,"Graft versus lymphoma effect early relapse following reduced-intensity allogenic stem cell transplantation for relapsed cytotoxic variant of mycosis fungoides [6]","Gabriel I.H., Olavarria E., Jones R.R., Whittaker S., Chaideos A., Apperley J.F.",02683369,"Bone Marrow Transplantation",40, 4,0,0,1,1,0,1
2007,"Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: Long term follow-up of an EBMT phase III randomized study","Bourhis J.-H., Samson D., Bjorkstrand B., Niederwieser D., Gahrton G., Pico J.-L., Goldschmidt H., Bouko Y., Koscielny S., Bakkus M., Greinix H., Derigs G., Salles G., Feremans W., Apperley J.",03906078,"Haematologica",92, 8,0,0,2,2,3,5
2007,"The polycomb group BMI1 gene is a molecular marker for predicting prognosis of chronic myeloid leukemia","Mohty M., Yong A.S.M., Szydlo R.M., Apperley J.F., Melo J.V.",00064971,"Blood",110, 1,0,3,9,12,3,15
2007,"Risk assessment in haemotopoietic stem cell transplantation: Disease and disease stage","Chaidos A., Kanfer E., Apperley J.F.",15216926,"Best Practice and Research: Clinical Haematology",20, 2,0,0,1,1,3,4
2007,"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia","Jovanovic J.V., Hochhaus A., Roche-Lestienne C., Preudhomme C., Solomon E., Apperley J., Rondoni M., Ottaviani E., Martinelli G., Brito-Babapulle F., Saglio G., Score J., Hehlmann R., Cross N.C.P., Reiter A., Grimwade D., Waghorn K., Cilloni D., Gottardi E., Metzgeroth G., Erben P., Popp H., Walz C.",00064971,"Blood",109, 11,0,10,24,34,10,44
2007,"Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: A phase I/II study in patients in complete haematological remission","Pavlu J., Andreasson C., Chuah C., Kaeda J., Goldman J.M., Apperley J.F., Marin D.",00071048,"British Journal of Haematology",137, 5,0,1,0,1,0,1
2007,"Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase","Guilhot F., Hochhaus A., Heim D., Larson R.A., Branford S., Muller M.C., Agarwal P., Gollerkeri A., Talpaz M., Apperley J., Kim D.-W., Bullorsky E.O., Baccarani M., Roboz G.J., Amadori S., De Souza C.A., Lipton J.H.",00064971,"Blood",109, 10,0,25,59,84,33,117
2007,"Total CD34+ cells per 10 HPF in bone marrow trephines of patients with chronic myeloid leukaemia correlates with probability of complete cytogenetic response following imatinib treatment [9]","Elliot V., Marin D., Horncastle D., Elderfield K., Howard J., Apperley J.F., Lampert I.A., Naresh K.N.",03090167,"Histopathology",50, 6,0,0,0,0,0,0
2007,"Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: The importance of escalating the cell dose to maximize therapeutic efficacy","Simula M.P., Marin D., Olavarria E., Goldman J.M., Apperley J.F., Dazzi F., Marktel S., Fozza C., Kaeda J., Szydlo R.M., Nadal E., Bua M., Rahemtulla A., Kanfer E.",08876924,"Leukemia",21, 5,0,2,5,7,0,7
2007,"Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis","Cortes J., Apperley J., Ottmann O., Shah N., Erben P., Branford S., Agarwal P., Gollerkeri A., Baccarani M., Rousselot P., Kim D.-W., Ritchie E., Hamerschlak N., Coutre S., Hochhaus A., Guilhot F., Saglio G.",00064971,"Blood",109, 8,0,26,60,86,31,117
2007,"Reduced-intensity conditioning for myeloma: Lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning","Crawley C., Iacobelli S., Bjorkstrand B., Apperley J.F., Niederwieser D., Gahrton G.",00064971,"Blood",109, 8,0,16,11,27,8,35
2007,"Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy","Hochhaus A., Niederwieser D., Silver R.T., Stone R.M., Hughes T.P., Muller M.C., Ezzeddine R., Countouriotis A.M., Shah N.P., Kantarjian H.M., Baccarani M., Lipton J.H., Apperley J.F., Druker B.J., Facon T., Goldberg S.L., Cervantes F.",00064971,"Blood",109, 6,0,36,68,104,39,143
2007,"Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","Nadal E., Garin M., Kaeda J., Apperley J., Lechler R., Dazzi F.",08876924,"Leukemia",21, 3,0,1,8,9,2,11
2007,"Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: Lack of association with cell dose","Fozza C., Szydlo R.M., Abdel-Rehim M.M., Nadal E., Goldman J.M., Apperley J.F., Dazzi F.",00071048,"British Journal of Haematology",136, 6,0,1,3,4,1,5
2007,"Haematopoietic stem cell transplantation for vasculitis including Behçet's disease and polychondritis: A retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature","Daikeler T., Porretto F., Musso M., Maurer B., Rinaldi N., Saccardi R., Tyndall A., Kotter I., Tyndall C.B., Apperley J., Attarbaschi A., Guardiola P., Gratwohl A., Jantunen E., Marmont A.",00034967,"Annals of the Rheumatic Diseases",66, 2,0,3,12,15,6,21
2007,"Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders","David M., Hughes G., Huguet F., Lavender L., McArthur G.A., Mahon F.X., Massimini G., Melo J., Rousselot P., Russell-Jones R.J., Seymour J.F., Cross N.C.P., Smith G., Stark A., Waghorn K., Nikolova Z., Apperley J.F., Burgstaller S., Chase A., Curtis C., Dang R., Gardembas M., Goldman J.M., Grand F.",00064971,"Blood",109, 1,0,9,12,21,7,28
2007,"Radiation Emergencies: Evaluation, Management, and Transplantation","Weisdorf D., Apperley J., Courmelon P., Gorin N.-C., Wingard J., Chao N.",10838791,"Biology of Blood and Marrow Transplantation",13, 1,0,0,0,0,0,0
2007,"LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: Treatment outcome and risk factor analysis in 67 patients from a single centre","Perz J.B., Marin D., Apperley J., Olavarria E., Rahemtulla A., Lampert I., Naresh K., Samson D., MacDonald D., Kanfer E.J., Giles C., Szydlo R., O'Shea D., Sanz J., Chaidos A., Wagner S., Davis J., Loaiza S.",02683369,"Bone Marrow Transplantation",39, 1,0,1,0,1,1,2
2006,"Managing the patient with chronic myeloid leukemia through and after allogeneic stem cell transplantation.","Apperley J.F.",15204391,"Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",, ,0,2,3,5,1,6
2006,"Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation [4]","Perz J.B., Kristen A.V., Rahemtulla A., Parameshwar J., Sack F.-U., Apperley J.F., Goldschmidt H., Katus H.A., Dengler T.J.",18610684,"Clinical Research in Cardiology",95, 12,0,1,1,2,3,5
2006,"Varying response to escalating the dose of imatinib in patients with CML who ""acquire"" a BCR-ABLM244V mutant allele","Anand M., Khorashad J., Marin D., Apperley J.F., Goldman J.M., Kaeda J.S.",00064971,"Blood",108, 8,0,2,0,2,1,3
2006,"Consensus conference on European preparedness for haematological and other medical management of mass radiation accidents","Gorin N.-C., Fliedner T.M., Gourmelon P., Ganser A., Meineke V., Sirohi B., Powles R., Apperley J.",09395555,"Annals of Hematology",85, 10,0,4,0,4,3,7
2006,"Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: Indirect assessment of the effect of day 11 methotrexate administration","Bensinger W.I., Couban S., Cutler C., Djulbegovic B., Gratwohl A., Heldal D., Hills R.K., Hozo I., Kuentz M., Kumar A., Lipton J.H., Al-Jurf M., Miranda E.C.M., Mohty M., Matcham J., Morton J., Panzarella T., Powles R., Richards S., Sahovic E., Schmitz N., Simpson D.R., Annasetti C., Sirohi B., Soares H.P., de Souza C.A., Van der Holt B., Vigorito A.C., Wheatley K., Apperley J.F., Baynes R., Blaise D., Clarke M., Colcol E., Cornelissen J.J.",02683369,"Bone Marrow Transplantation",38, 8,0,2,1,3,3,6
2006,"Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet","Baccarani M., Deininger M., Gratwohl A., Guilhot F., Horowitz M., Hughes T., Kantarjian H., Larson R., Niederwieser D., Silver R., Hehlmann R., Saglio G., Goldman J., Hochhaus A., Simonsson B., Appelbaum F., Apperley J., Cervantes F., Cortes J.",00064971,"Blood",108, 6,12,79,108,187,70,269
2006,"The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: A British society of blood and marrow transplantation study","Bird J.M., Littlewood T., Fegan C., McQuaker G., Pagliuca A., Johnson P., Rahemtulla A., Morris C., Marks D.I., Fuge R., Sirohi B., Apperley J.F., Hunter A., Snowden J., Mahendra P., Milligan D., Byrne J.",00071048,"British Journal of Haematology",134, 4,0,5,2,7,2,9
2006,"Imatinib preceding allogeneic stem cell transplantation in chronic myeloid leukemia","Perz J.B., Khorashad J.S., Marin D., Apperley J.F., Olavarria E.",03906078,"Haematologica",91, 8,0,1,2,3,0,3
2006,"Assessing the potential role of photopheresis in hematopoietic stem cell transplant","Greinix H.T., Knobler R.M., Peritt D., Ferrara J.L.M., Socie G., Bacigalupo A., Holler E., Edinger M.G., Apperley J.F., Schwarz T., Ullrich S.E., Albert M.L.",02683369,"Bone Marrow Transplantation",38, 4,0,4,9,13,2,15
2006,"Never say never again!","Apperley J.F.",00064971,"Blood",108, 3,0,0,0,0,0,0
2006,"Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor","Gordon M.Y., Marley S.B., Davies J., Dazzi F., Marelli-Berg F., Tait P., Playford R., Jiao L., Jensen S., Nicholls J.P., Ayav A., Levicar N., Nohandani M., Farzaneh F., Gaken J., Dodge R., Alison M., Apperley J.F., Lechler R., Habib N.A., Pai M., Bachellier P., Dimarakis I., Al-Allaf F., M'Hamdi H., Thalji T., Welsh J.P.",10665099,"Stem Cells",24, 7,1,13,23,36,4,41
2006,"Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: An attempt to define patients who may not require further therapy","Kaeda J., Goldman J.M., Apperley J.F., O'Shea D., Szydlo R.M., Olavarria E., Dazzi F., Marin D., Saunders S., Khorashad J.S., Cross N.C.P.",00064971,"Blood",107, 10,3,10,6,16,5,24
2006,"Long-term outcome of high-dose melphalan and autologous stem cell transplantation for AL amyloidosis","Perz J.B., Apperley J.F., Rahemtulla A., Giles C., Szydlo R.M., Davis J., Gopaul D., Gillmore J., Mathias C.J., Hawkins P.N.",02683369,"Bone Marrow Transplantation",37, 10,1,0,1,1,2,4
2006,"Topical issues in unrelated donor haematopoietic stem cell transplants: A report from a workshop convened by the Anthony Nolan Trust in London - 2005","Duarte R.F., Apperley J.F., Madrigal J.A., Goldman J.M., Pamphilon D., Cornish J., Shaw B.E., Samson D., Craddock C., Marks D., Mufti G.J., Powles R.L.",02683369,"Bone Marrow Transplantation",37, 10,0,0,0,0,0,0
2006,"Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: Transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","Gratwohl A., Kolb H.-J., Niederwieser D., Brand R., Apperley J., Crawley C., Ruutu T., Corradini P., Carreras E., Devergie A., Guglielmi C.",03906078,"Haematologica",91, 4,6,21,25,46,8,60
2006,"Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: A single-centre experience in 211 patients","O'Shea D., Narat S., Kanfer E., Olavarria E., Apperley J.F., Rahemtulla A., Giles C., Terpos E., Perz J., Politou M., Sana V., Naresh K., Lampert I., Samson D.",02683369,"Bone Marrow Transplantation",37, 8,3,13,10,23,9,35
2006,"The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib","Khorashad J.S., Apperley J.F., Kaeda J., Anand M., Marin D., Saunders S., Al-Jabary T., Iqbal A., Margerison S., Melo J.V., Goldman J.M.",08876924,"Leukemia",20, 4,6,16,21,37,13,56
2006,"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe","Ljungman P., Passweg J., Rocha V., Saccardi R., Schouten H., Schmitz N., Socie G., Sureda A., Apperley J., Urbano-Ispizua A., Cavazzana-Calvo M., Demirer T., Dini G., Einsele H., Gratwohl A., Madrigal A., Niederwieser D.",02683369,"Bone Marrow Transplantation",37, 5,8,24,27,51,14,73
2006,"No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib [1]","Politou M., Karadimitris A., Terpos E., Kotsianidis I., Apperley J.F., Rahemtulla A.",01452126,"Leukemia Research",30, 2,0,1,1,2,1,3
2006,"Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML","Yong A.S.M., Szydlo R.M., Goldman J.M., Apperley J.F., Melo J.V.",00064971,"Blood",107, 1,6,9,14,23,9,38
2005,"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials","Al-Jurf M., Cornelissen J.J., Couban S., Cutler C., Djulbegovic B., Gyger M., Gratwohl A., Heldal D., Hills R.K., Van Der Holt B., Hozo I., Aranha F., Kuentz M., Kumar A., Lipton J., Matcham J., Mohty M., Morton J., Panzarella T., Powles R., Richards S.M., Sahovic E., Annasetti C., Schmitz N., Simpson D.R., Sirohi B., Soares H.P., De Souza C.A., Vigorito A.C., Wheatley K., Apperley J.F., Baynes R., Bensinger W.I., Blaise D., Chaudhary M.A., Clarke M.",0732183X,"Journal of Clinical Oncology",23, 22,24,25,19,44,14,82
2005,"Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma","Terpos E., Rezvani K., Basu S., Milne A.E., Rose P.E., Scott G.L., Rahemtulla A., Samson D., Apperley J.F.",09024441,"European Journal of Haematology",75, 5,1,4,1,5,4,10
2005,"Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells","Xue S.-A., Morris E., Stauss H., Gao L., Hart D., Gillmore R., Qasim W., Thrasher A., Apperley J., Engels B., Uckert W.",00064971,"Blood",106, 9,7,15,14,29,8,44
2005,"Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: An analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT","Crawley C., Passweg J., Komarnicki M., Vitek A., Mayer J., Zander A., Sierra J., Rambaldi A., Ringden O., Niederwieser D., Apperley J.F., Szydlo R., Lalancette M., Bacigalupo A., Lange A., Brune M., Juliusson G., Nagler A., Gratwohl A.",00064971,"Blood",106, 9,18,24,12,36,5,59
2005,"Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: A report of the EBMT activity survey 2003","Gratwohl A., Chesnel V., Gorin N.C., Ljungman P., Ruiz de Elvira C., Jouet J.P., Chir Z., Hagenbeek A., Biezen Av., Sneets M., Greinix H., Baldomero H., Lindner B., Vignetti M., Bacigalupo A., Oneto R., Bruno B., Ottinger H., Westphal M., Towlson K., Apperley J., Wilson M., Schmid O., Gurman G., Arat M., Arpaci F., Ertem M., Benesova K., Trnkova M., Naya M., Horisberger B., Bargetzi M., Urbano-Ispizua A., McDonald F., McGrath E., Notely S.",02683369,"Bone Marrow Transplantation",36, 7,14,7,7,14,1,29
2005,"Anti-angiogenic effect of bortezomib in patients with multiple myeloma","Politou M., Naresh K., Terpos E., Crawley D., Lampert I., Apperley J.F., Rahemtulla A.",00015792,"Acta Haematologica",114, 3,0,2,1,3,0,3
2005,"Percentage of CD34+ cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count [3]","Elliot V., Marin D., Horncastle D., Elderfield K., Apperley J.F., Lampert I.A., Naresh K.",00071048,"British Journal of Haematology",130, 3,1,1,1,2,1,4
2005,"Analysis of total phosphotyrosine levels in CD34+ cells from CML patients to predict the response to imatinib mesylate treatment [2]","Schultheis B., Szydlo R., Mahon F.X., Apperley J.F., Melo J.V.",00064971,"Blood",105, 12,5,5,4,9,2,16
2005,"Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: An analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT","Crawley C., Shimoni A., Sureda A., Boiron J.-M., Einsele H., Chopra R., Carella A., Cavenagh J., Gratwohl A., Garban F., Zander A., Lalancette M., Bjorkstrand B., Niederwieser D., Gahrton G., Apperley J.F., Szydlo R., Gilleece M., Peggs K., Mackinnon S., Juliusson G., Ahlberg L., Nagler A.",00064971,"Blood",105, 11,35,29,12,41,10,86
2005,"Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib","Marin D., Kaeda J.S., Andreasson C., Saunders S.M., Bua M., Olavarria E., Goldman J.M., Apperley J.F.",0008543X,"Cancer",103, 9,13,6,6,12,2,27
2005,"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-Year results from the EBMT randomized trial","Schmitz N., Bradstock K., Buzyn A., Schlegelberger B., Matcham J., Gratwohl A., Beksac M., Bacigalupo A., Ruutu T., Nagler A., Gluckman E., Russell N., Apperley J., Szer J.",03906078,"Haematologica",90, 5,4,5,0,5,2,11
2005,"Personalized medical treatment strategies for patients with chronic myeloid leukemia","Burton C., Marin D., Apperley J.",14737140,"Expert Review of Anticancer Therapy",5, 2,0,0,0,0,0,0
2005,"Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: Patterns of residual leukaemia and prognostic factors for cytogenetic relapse","Marin D., Rahemtulla A., Dazzi F., Kanfer E., Goldman J.M., Apperley J.F., Kaeda J., Szydlo R., Saunders S., Fleming A., Howard J., Andreasson C., Bua M., Olavarria E.",08876924,"Leukemia",19, 4,14,8,10,18,10,42
2005,"The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: Reduced relapse risk in female to male transplants","Gahrton G., Corradini P., Kroger N., Ljungman P., Michallet M., Russell N.H., Samson D., Schattenberg A., Sirohi B., Verdonck L.F., Volin L., Iacobelli S., Zander A., Niederwieser D., Apperley J., Bandini G., Bjorkstrand B., Blade J., Boiron J.M., Cavo M., Cornelissen J.",02683369,"Bone Marrow Transplantation",35, 6,4,2,5,7,2,13
2005,"Minimal residual disease monitoring in multiple myeloma: Flow cytometry is the method of choice [2] (multiple letters)","Owen R.G., Goldschmidt H., Moos M., Bakkus M.H.C., Rawstron A.C., Cremer F.W., Bouko Y., Samson D., Apperley J.F., Thielemans K., Van Camp B., Benner A.",00071048,"British Journal of Haematology",128, 5,3,2,2,4,1,8
2005,"Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: A survey of the European Group for Blood and Marrow Transplantation (EBMT)","Ruutu T., Niederwieser D., Corradini P., Gratwohl A., Holler E., Apperley J., Dini G., Rocha V., Schmitz N., Socie G.",02683369,"Bone Marrow Transplantation",35, 2,0,0,4,4,0,4
2004,"Evolution of hematopoietic stem cell transplantation in eastern and western Europe from 1990 to 2003. A report from the EBMT activity survey","Gratwohl A., Baldomero H., Labar B., Apperley J., Urbano-Ispizua A.",03539504,"Croatian Medical Journal",45, 6,4,3,5,8,2,14
2004,"Autologous/syngeneic stem cell transplantation to treat refractory GvHD","Passweg J.R., Orchard K., Buergi A., Gratwohl A., Powles R., Goldman J., Apperley J., Mehta J.",02683369,"Bone Marrow Transplantation",34, 11,2,0,2,2,0,4
2004,"The FIP1L1-PDGFRA syndrome: A case of mistaken identity?","Apperley J., Bain B.",00064971,"Blood",104, 10,2,1,0,1,0,3
2004,"Just Another Cost Increasing Exercise (JACIE)?","Apperley J.",02683369,"Bone Marrow Transplantation",34, 10,0,0,2,2,1,3
2004,"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)","Politou M., Terpos E., Anagnostopoulos A., Szydlo R., Laffan M., Layton M., Apperley J.F., Dimopoulos M.-A., Rahemtulla A.",00071048,"British Journal of Haematology",126, 5,15,7,4,11,2,28
2004,"Post-transplantation tumour load in bone marrow, as assessed by quantitative ASO-PCR, is a prognostic parameter in multiple myeloma","Bakkus M.H.C., Cremer F.W., Bouko Y., Samson D., Apperley J.F., Thielemans K., Van Camp B., Benner A., Goldschmidt H., Moos M.",00071048,"British Journal of Haematology",126, 5,5,4,5,9,1,15
2004,"Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma","Terpos E., Rahemtulla A., Politou M., Szydlo R., Nadal E., Avery S., Olavaria E., Kanfer E., Goldman J.M., Apperley J.F.",08876924,"Leukemia",18, 8,14,5,1,6,1,21
2004,"Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia","Radich J.P., Olavarria E., Apperley J.F.",08898588,"Hematology/Oncology Clinics of North America",18, 3,11,5,3,8,2,21
2004,"Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib","Avery S., Nadal E., Marin D., Olavarria E., Kaeda J., Vulliamy T., Brito Babapulle F., Goldman J.M., Apperley J.F.",01452126,"Leukemia Research",28, 1,6,0,1,1,0,7
2004,"Interactive web-based guidelines for chronic myeloid leukaemia [5]","Marin D., Rahemtulla A., Olavarria E., Goldman J., Apperley J.",01406736,"Lancet",363, 9416,0,0,0,0,0,0
2004,"Prolonged effect of reduced intensity conditioning (RIC) allogeneic transplantation for multiple myeloma on biochemical markers of bone remodelling and osteoclast function: Report of a case","Politou M., Terpos E., Nadal E., Crawley C., Apperley J.F., Rahemtulla A.",11082682,"HAEMA",7, 1,0,0,1,1,0,1
2004,"A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation","Zino E., Bontadini A., Bonifazi F., Lisini D., Mazzi B., Rossini S., Servida P., Ciceri F., Bonini C., Lanino E., Bandini G., Frumento G., Locatelli F., Apperley J., Bacigalupo A., Ferrara G.B., Bordignon C., Fleischhauer K., Marktel S., Sormani M.P., Ficara F., Di Terlizzi S., Parodi A.M., Sergeant R., Martinetti M.",00064971,"Blood",103, 4,7,8,6,14,0,21
2004,"Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions","Nadal E., Fowler A., Kanfer E., Apperley J., Goldman J., Dazzi F.",0301472X,"Experimental Hematology",32, 2,8,2,2,4,0,12
2004,"The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland","Russell N.H., Szydlo R., McCann S., Potter M.N., Craddock C., Towlson K., Apperley J.F.",00071048,"British Journal of Haematology",124, 4,1,1,0,1,1,3
2003,"Chronic myeloid leukemia.","Melo J.V., Hughes T.P., Apperley J.F.",15204391,"Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program",, ,20,11,1,12,3,35
2003,"Differences between graft product and donor side effects following bone marrow or stem cell donation","Favre G., Bradstock K., Buzyn A., Matcham J., Gratwohl A., Schmitz N., Greinix H., Niederwieser D., Nachbauer D., Boogaerts M., Ferrant A., Beksac M., Arnold R., Gorin N.C., Frickhofen N., Zander A., McCann S., Bacigalupo A., Ringden O., Majolino I., Jouet J.P., Varet B., Finke J., Smith G., Bosi A., Lambertenghi-Deliliers G., Ruutu T., Kolbe K., Bradstock K.A., Lioure B., Hughes T., Herrmann R., Trumper L., Falda M., Nagler A., Nikiforakis E., Abecasis M., Rowe J., Potter M., Wandt H., Schwerdtfeger R., Casper J., Pagliuca A., Gluckman E., Russell N., Apperley J., Szer J.",02683369,"Bone Marrow Transplantation",32, 9,14,2,2,4,4,22
2003,"Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional doses [7] (multiple letters)","Marin D., Goldman J.M., Olavarria E., Apperley J.F., Cortes J., Kantarjian H.",00064971,"Blood",102, 7,9,5,6,11,9,29
2003,"Serum levels of macrophage inflammatory protein-1 alpha (MIP-1?) correlate with the extent of bone disease and survival in patients with multiple myeloma","Terpos E., Politou M., Szydlo R., Goldman J.M., Apperley J.F., Rahemtulla A.",00071048,"British Journal of Haematology",123, 1,28,6,5,11,5,44
2003,"Survival of patients with chronic-phase chronic myeloid leukaemia on imatinib after failure on interferon alfa","Marin D., Goldman J.M., Apperley J.F., Marktel S., Szydlo R., Klein J.P., Bua M., Foot N., Olavarria E., Shepherd P., Kanfer E.",01406736,"Lancet",362, 9384,26,1,3,4,0,30
2003,"Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response","Seaton E.D., Szydlo R.M., Kanfer E., Apperley J.F., Russell-Jones R.",00064971,"Blood",102, 4,26,6,5,11,0,37
2003,"Stem cell transplantation for chronic myeloid leukemia in children","Cwynarski K., Locatelli F., Dini G., Niethammer D., Niederwieser D., Apperley J.F., Roberts I.A.G., Iacobelli S., Van Biezen A., Brand R., Devergie A., Vossen J.M., Aljurf M., Arcese W.",00064971,"Blood",102, 4,18,5,5,10,2,30
2003,"Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons","Gordon M.Y., Marley S.B., Apperley J.F., Marin D., Kaeda J., Szydlo R., Goldman J.M.",00071048,"British Journal of Haematology",122, 3,3,0,1,1,0,4
2003,"Soluble receptor activator of nuclear factor ?B ligand-osteoprotegerin ratio predicts survival in multiple myeloma: Proposal for a novel prognostic index","Terpos E., Rahemtulla A., Szydlo R., Apperley J.F., Hatjiharissi E., Politou M., Meletis J., Viniou N., Yataganas X., Goldman J.M.",00064971,"Blood",102, 3,77,20,30,50,12,139
2003,"Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa","Marin D., Olavarria E., Lennard A., Neylon A., O'Brien S.G., Goldman J.M., Apperley J.F., Marktel S., Bua M., Szydlo R.M., Franceschino A., Nathan I., Foot I., Crawley C., Nakorn T.N.",08876924,"Leukemia",17, 8,20,4,5,9,4,33
2003,"Imatinib or transplant for chronic myeloid leukaemia? [7] (multiple letters)","Goldman J., Apperley J., Kanfer E., Olavarria E., Marin D., Craddock C., Augustson B., Basu S.",01406736,"Lancet",362, 9378,2,0,0,0,0,2
2003,"Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation","Orlent H., Crawley C., Cwynarski K., Dina R., Apperley J.",02683369,"Bone Marrow Transplantation",32, 1,8,0,0,0,4,12
2003,"Monitoring CML after nonmyeloablative transplantations: How negative is negative? [1] (multiple letters)","Kaeda J., Slavin S., Apperley J., Melo J., Cross N., Goldman J., Shapira M.Y., Or R., Resnick I.B., Bitan M.",00064971,"Blood",101, 12,0,0,0,0,0,0
2003,"Clinical decisions for chronic myeloid leukemia in the imatinib era","Goldman J.M., Marin D., Olavarria E., Apperley J.F.",00371963,"Seminars in Hematology",40, 2,14,4,1,5,1,20
2003,"Safety of retroviral gene marking with a truncated NGF receptor [1]","Bonini C., Deola S., Radrizzani M., Hagenbeek A., Apperley J., Ebeling S., Martens A., Kolb H.J., Weber M., Lotti F., Grande A., Grez M., Weissinger E., Bueren J.A., Lamana M., Falkenburg J.H.F., Heemskerk M.H.M., Austin T., Kornblau S., Marini F., Benati C., Magnani Z., Traversari C., Cazzaniga S., Toma S., Gallo-stampino C., Introna M., Slavin S., Greenberg P.D., Bregni M., Mavilio F., Bordignon C., Ciceri F., Marktel S., Ferrari G., Dinauer M., Sadat M., Aiuti A.",10788956,"Nature Medicine",9, 4,45,11,8,19,2,66
2003,"Chronic myeloid leukemia in chronic phase responding to imatinib: The occurrence of additional cytogenetic abnormalities predicts disease progression","Marktel S., Rahemtulla A., Olavarria E., Apperley J.F., Goldman J.M., Marin D., Foot N., Szydlo R., Bua M., Karadimitris A., De Melo V.A.S., Kotzampaltiris P., Dazzi F.",03906078,"Haematologica",88, 3,30,10,8,18,3,51
2003,"Autologous stem cell transplantation in multiple myeloma: Improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients","Terpos E., Apperley J.F., Samson D., Giles C., Crawley C., Kanfer E., Olavarria E., Goldman J.M., Rahemtulla A.",02683369,"Bone Marrow Transplantation",31, 3,19,5,3,8,1,28
2003,"Granulocyte colony-stimulating factor reverses cytopenia and may permit cytogenetic responses in patients with chronic myeloid leukemia treated with imatinib mesylate","Marin D., Marktel S., Foot N., Bua M., Olavarria E., Galdman J.M., Apperley J.F.",03906078,"Haematologica",88, 2,14,3,2,5,2,21
2002,"Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia","Gratwohl A., Iacobelli S., Michallet M., Kolb H.-J., Ruutu T., Niederwieser D., Brand R., Apperley J., Biezen A.V., Bandini G., Devergie A., Schattenberg A., Frassoni F., Guglielmi C.",00064971,"Blood",100, 12,36,11,6,17,2,55
2002,"Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL","Bellantuono I., Gao L., Parry S., Marley S., Dazzi F., Apperley J., Goldman J.M., Stauss H.J.",00064971,"Blood",100, 10,38,7,9,16,5,59
2002,"Prognostic factors for acute graft-versus-host disease after donor lymphocyte infusions [2]","Dazzi F., Szydlo R.M., Apperley J.F., Goldman J.M.",00064971,"Blood",100, 7,3,2,0,2,0,5
2002,"Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: A survey of the European Group for Blood and Marrow Transplantation (EBMT)","Ruutu T., Verdonck L.F., Prentice H.G., Bosi A., Du Toit C.E., Brinch L., Apperley J.F., Hermans J., Niederwieser D., Gratwohl A., Kiehl M., Volin L., Bertz H., Ljungman P., Spence D.",00071048,"British Journal of Haematology",118, 4,28,9,4,13,3,44
2002,"The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase","Olavarria E., Cahn J.-Y., Jouet J.P., Rizzoli V., Van Biezen A., Gratwohl A., Goldman J.M., Niederwieser D., Apperley J.F., Reiffers J., Boque C., Sureda A., Meloni G., Michallet M., Clark R.E., Blaise D., Carella A.M.",00071048,"British Journal of Haematology",118, 3,8,2,0,2,0,10
2002,"Major radiation exposure [2] (multiple letters)","Forman S.J., Gunalp B., Souchkevitch G., Mettler Jr. F.A., Voelz G.L., Petz L.D., Powles R., Apperley J., Van Bekkum D.W., Noteboom J.L., Goddard C.M., Turai I., Veress K.",00284793,"New England Journal of Medicine",347, 12,1,0,0,0,1,2
2002,"The use of imatinib (STI571) in chronic myeloid leukemia: Some practical considerations","Marin D., Marktel S., Bua M., Armstrong L., Goldman J.M., Apperley J.F., Olavarria E.",03906078,"Haematologica",87, 9,23,2,2,4,2,29
2002,"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","Apperley J.F., Dearden C.E., Dimitrijevic S., Mahon F.-X., Marin D., Nikolova Z., Olavarria E., Silberman S., Schultheis B., Cross N.C.P., Goldman J.M., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J., Baxter E.J., Chase A., Chessells J.M., Colombat M.",00284793,"New England Journal of Medicine",347, 7,238,52,36,88,20,346
2002,"Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia","Schmitz N., Gorin N.C., Szer J., Bradstock K., Buzyn A., Clark P., Borkett K., Gratwohl A., Beksac M., Hasenclever D., Bacigalupo A., Ruutu T., Nagler A., Gluckman E., Russell N., Apperley J.F.",00064971,"Blood",100, 3,88,13,10,23,4,115
2002,"Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: Prognostic relevance of the initial cell dose","Guglielmi C., Devergie A., Bacigalupo A., Gomez M., Michallet M., Elmaagacli A., Gratwohl A., Apperley J., Niederwieser D., Arcese W., Dazzi F., Brand R., Bunjes D., Verdonck L.F., Schattenberg A., Kolb H.-J., Ljungman P.",00064971,"Blood",100, 2,59,8,16,24,3,86
2002,"Not so NICE for CML [1]","Goldman J., Apperley J., Clark R., Green T., Holyoake T., O'Brien S., Shepherd P.",01406736,"Lancet",359, 9322,2,0,0,0,0,2
2002,"Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation","Olavarria E., Craddock C., Dazzi F., Marin D., Marktel S., Apperley J.F., Goldman J.M.",00064971,"Blood",99, 10,42,2,5,7,2,51
2002,"Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia","Wadhwa J., Szydlo R.M., Apperley J.F., Chase A., Bua M., Marin D., Olavarria E., Kanfer E., Goldman J.M.",00064971,"Blood",99, 7,36,3,3,6,1,43
2002,"Survival after bone-marrow transplantation [1] (multiple letters)","Cwynarski K., Craddock C., Cobbold M., Apperley J., Goldman J., Nachbaur D., Remberger M., Ringden O., Szydlo R.",01406736,"Lancet",359, 9309,3,0,0,0,0,3
2002,"Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms","Sauce D., Herve P., Lang F., Tiberghien P., Robinet E., Bodinier M., Garin M., Petracca B., Tonnelier N., Duperrier A., Melo J.V., Apperley J.F., Ferrand C.",00064971,"Blood",99, 4,52,14,10,24,3,79
2002,"STI571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response","Hasserjian R.P., Apperley J.F., Goldman J.M., Boecklin F., Parker S., Chase A., Dhar S., Zaiac M., Olavarria E., Lampert I., Henry K.",00029173,"American Journal of Clinical Pathology",117, 3,25,5,2,7,1,33
2002,"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe","Urbano-Ispizua A., Socie G., Tyndall A., Niethammer D., Ljungman P., Gratwohl A., Apperley J., Niederwieser D., Bacigalupo A., Schmitz N., de Witte T., Frassoni F., Rosti G., Schrezenmeier H., Gluckman E., Friedrich W., Cordonnier C.",02683369,"Bone Marrow Transplantation",29, 8,48,2,3,5,4,57
2001,"Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: Comparison with unrelated donor transplantation and autologous stem cell transplantation","De Witte T., Kuentz M., Harousseau J., Fauser A., Wandt H., Runde V., Niederwieser D., Apperley J., Pikkemaat F., Hermans J., Van Biezen A., Mackinnan S., Cornelissen J., Gratwohl A., Delforge M., Iriondo A.",08876924,"Leukemia",15, 12,13,1,0,1,2,16
2001,"Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: The first dose decides outcome","Guglielmi C., Bacigalupo A., Gomez M., Michallet M., Elmaagacli A., Gratwohl A., Apperley J., Niederwieser D., Arcese W., Dazzi F., Bunjes D., Verdonck L.F., Schattenberg A., Kolb H.-J., Ljungman P., Devergie A.",00064971,"Blood",98, 11,0,0,0,0,0,0
2001,"The combination of cytogenetic response after 6 months treatment with STI571 and the presence of cytopenias in patients with CML in chronic phase resistant to or intolerant of interferon-alfa defines four different prognostic groups","Marin D., Apperley J.F., Bua M., Markte S., Chase A., Udom C., Armstrong L., Oilleece M.H., Olavarria E., Goldman J.M.",00064971,"Blood",98, 11,8,1,0,1,0,9
2001,"Analysis of prognostic factors on the outcome of autologous and allogeneic stem cell transplantations (SCT) for chronic lymphocytic leukemia (CLL)","Michallet M., Niederwieser D., Brand R., Dreger P., Millighan D., Esteve J., Kimby E., Nicolini F., Apperley J., Van Biezen A.",00064971,"Blood",98, 11,5,2,0,2,0,7
2001,"A time interval > 12 months from diagnosis to transplant is associated with increased acute graft-versus-host disease in patients transplanted for chronic myeloid leukemia","Gratwohl A., Kolb H., Ruutu T., Niederwieser D., Brand R., Van Biezen A., Apperley J., Bandini G., Devergie A., Frassoni F., Guglielmi C., Michallet M.",00064971,"Blood",98, 11,0,0,0,0,0,0
2001,"Oligoclonal reconstitution after high dose therapy with PBPCT in myeloma patients: Implications for assessment of remission status","Bouko Y., Goldschmidt H., Feremans W., Bourhis J.-H., Greinix H., Pico J.-L., Apperley J., Gahrton G., Samson D.",00064971,"Blood",98, 11,0,0,0,0,0,0
2001,"Chronic myeloproliferative diseases with t(5;12) and a PDGFRB fusion gene: Complete cytogenetic remissions on STI571","Apperley J.F., Russell-Jones R., Melo J., Goldman J., Schultheis B., Chase A., Steer J., Bain B., Dimitrijevic S., Marin D., Olavarria E., Cross N.",00064971,"Blood",98, 11,9,0,0,0,0,9
2001,"Response of chronic phase CML patients to STI571 therapy assessd by quantitative real time PCR","Lin F., Apperley J.F., Goldman J.M., Kaeda J.S., Chase A., O'Brien S.G., Saunders S.M., Lennard A.L., McLean R.A., Marin D., Cross N.C.P., Olavarria E.",00064971,"Blood",98, 11,0,0,0,0,0,0
2001,"Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants","Gratwohl A., Hermans J., Niederwieser D., Van Biezen A., Van Houwelingen H.C., Apperley J.",14664860,"Hematology Journal",2, 6,33,3,3,6,2,41
2001,"Emergence of additional chromosomal abnormalities following treatment with STI571 (Imatinib mesylate) for philadelphia positive chronic myeloid leukemia in chronic phase","Marktel S., Bua M., Marin D., Chase A., Udom C., Armstrong L., Apperley J.F., Olavarria E., Goldman J.M.",00064971,"Blood",98, 11,10,1,0,1,0,11
2001,"Molecular studies in patients with chronic myeloid leukaemia in remission 5 years after allogeneic stem cell transplant define the risk of subsequent relapse","Mughal T.I., Kanfer E., Apperley J., Goldman J.M., Yong A., Szydlo R.M., Dazzi F., Olavarria E., Van Rhee F., Kaeda J., Cross N.C.P., Craddock C.",00071048,"British Journal of Haematology",115, 3,17,3,3,6,5,28
2001,"Pharmacokinetics of CAMPATH-1H in BMT patients","Rebello P., Cwynarski K., Varughese M., Eades A., Apperley J.F., Hale G.",14653249,"Cytotherapy",3, 4,42,4,5,9,0,51
2001,"Treatment options for blastic transformation of chronic myeloid leukemia and factors impacting on duration of survival","Wadhwa J., Szydlo R.M., Apperley J.F., Chase A., Bua M., Marin D., Olavarria E., Kanfer E., Goldman J.M.",00064971,"Blood",98, 11,0,0,0,0,0,0
2001,"Stem cell transplantation for chronic mycloid leukemia in children","Cwynarski K., Roberts I.A.G., Brand R., Van Biezen A., Slavin S., Vossen J., Wachowiak J., Niethammer D., Apperley J.",00064971,"Blood",98, 11,2,0,0,0,0,2
2001,"Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia: Association with leukaemic relapse and treatment with donor lymphocyte infusions","Cwynarski K., Lawler M., Goldman J.M., Goulding R., Pocock C., Dazzi F., Craddock C., Kaeda J., Olavarria E., Kanfer E., Apperley J.",02683369,"Bone Marrow Transplantation",28, 6,7,1,3,4,0,11
2001,"T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement","Olavarria E., Stewart S., Apperley J.F., Russell-Jones R., Child F., Woolford A., Whittaker S.J., Davis J.G., McDonald C., Chilcott S., Spittle M., Grieve R.J.",00071048,"British Journal of Haematology",114, 3,11,3,7,10,5,26
2001,"Autologous peripheral blood stem cell transplantation in tumor-stage mycosis fungoides: Predictors of disease-free survival","Russell-Jones R., Child F., Olavarria E., Whittaker S., Spittle M., Apperley J.",00778923,"Annals of the New York Academy of Sciences",941, ,6,1,3,4,1,11
2001,"Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene","Chalmers D., Tiberghien P., Garin M., Ferrand C., Apperley J.F., Melo J.V., Ebeling S., Newton I., Duperrier A., Hagenbeek A., Garrett E.",15250016,"Molecular Therapy",4, 2,14,4,3,7,1,22
2001,"Stem cell transplantation for chronic myeloid leukaemia: The role of infused marrow cell dose","Pocock C., Apperley J., Goldman J., Szydlo R., Davis J., de la Fuente J., Craddock C., Cwynarski K., Olavarria E., Rezvani K., Kanfer E.",14664860,"Hematology Journal",2, 4,5,0,0,0,1,6
2001,"HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia","Clark R.E., Hermans J., Madrigal A., Nachbaur D., Kropshofer G., Gratwohl A., Apperley J., Niederwieser D.",00071048,"British Journal of Haematology",114, 1,10,1,1,2,0,12
2001,"Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey","Salooja N., Hinterberger-Fischer M., Kolb H.J., Apperley J.F., Szydlo R.M., Socie G., Rio B., Chatterjee R., Ljungman P., Van Lint M.T., Powles R., Jackson G.",01406736,"Lancet",358, 9278,41,17,9,26,3,70
2001,"Immune neutropenia associated with anti-human neutrophil antigen-2a (NB1) antibodies following unrelated donor stem cell transplantation for chronic myeloid leukaemia: Perpetuation by granulocyte colony-stimulating factor","Pocock C.F., Lucas G.F., Giles C., Vassiliou G., Cwynarski K., Rezvani K., Apperley J.F., Goldman J.M.",00071048,"British Journal of Haematology",113, 2,2,1,1,2,1,5
2001,"BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir","Rivas C., Miller A.R.-M., Collado M., Lam E.W.-F., Apperley J.F., Melo J.V.",15250016,"Molecular Therapy",3, 5 I,3,1,0,1,0,4
2001,"Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: A comparison between transplants performed 1983-93 and 1994-98 at European Group for Blood and Marrow Transplantation centres","Gahrton G., Facon T., Ljungman P., Michallet M., Niederwieser D., Powles R., Reiffers J., Russell N.H., Samson D., Schaefer U.W., Schattenberg A., Svensson H., Tura S., Verdonck L.F., Vernant J.P., Willemze R., Volin L., Cavo M., Apperley J., Bacigalupo A., Bjorkstrand B., Blade J., Cornelissen J., De Laurenzi A.",00071048,"British Journal of Haematology",113, 1,134,24,8,32,10,176
2001,"Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: A retrospective registry study from the European group for blood and marrow transplantation (EBMT)","Bjorkstrand B., Remes K., Cornelissen J.J., Blade J., Lenhoff S., Iriondo A., Carlson K., Volin L., Littlewood T., Goldstone A.H., San Miguel J., Svensson H., Schattenberg A., Gahrton G., Goldschmidt H., Ljungman P., Apperley J., Mandelli F., Marcus R., Boogaerts M., Alegre A.",02683369,"Bone Marrow Transplantation",27, 5,40,9,0,9,0,49
2001,"Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia","Olavarria E., Apperley J.F., Cross N.C.P., Goldman J.M., Kanfer E., Szydlo R., Kaeda J., Rezvani K., Cwynarski K., Pocock C., Dazzi F., Craddock C.",00064971,"Blood",97, 6,76,10,5,15,2,93
2001,"Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment","Elizaga J., Olavarria E., Apperley J.F., Goldman J.M., Ward K.N.",10584838,"Clinical Infectious Diseases",32, 3,19,7,6,13,2,34
2001,"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","Cwynarski K., Ainsworth J., Cobbold M., Wagner S., Mahendra P., Apperley J., Goldman J., Craddock C., Moss P.A.H.",00064971,"Blood",97, 5,103,6,22,28,7,138
2001,"Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: The case for tailored graft-versus-host disease prophylaxis","Craddock C., Apperley J.F., Goldman J.M., Szydlo R.M., Dazzi F., Olavarria E., Cwynarski K., Yong A., Brookes P., De La Fuente J., Kanfer E.",00071048,"British Journal of Haematology",112, 1,37,9,5,14,2,53
2001,"Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene","Garin M.I., Garrett E., Tiberghien P., Apperley J.F., Chalmers D., Melo J.V., Ferrand C.",00064971,"Blood",97, 1,41,7,5,12,1,54
2000,"Donor lymphocyte infusions (dli) for cml: Factors influencing the effective cell dose and implications for the definition of refractoriness","Rezvani K., Dazzi F., Rahemtulla A., Cummins M., Cwynarski K., Gilleece M., Szydlo R., Kanfer E., Apperley J., Goldman J.",00064971,"Blood",96, 11,1,1,0,1,0,2
2000,"Prognostic relevance of acute graft-versus-host disease (agvhd) on outcome in patients transplanted with hla-identical sibling transplants for chronic myeloid leukemia (cml) in first chronic phase","Gratwohl A., Kolb H., Ruutu T., Niederwieser D., Brand R., Apperley J., Biezen A.V., Devergie A., De Witte T., Frassoni F., Guglielmi C., Michallet M.",00064971,"Blood",96, 11,1,0,0,0,0,1
2000,"Excellent outcome of non-myeloablative stem cell transplant (NMSCT) for good risk myeloma: The EBMT experience","Lalancette M., Gahrton G., Apperley J., Rezvani K., Szydlo R., Mackinnon S., Juliusson G., Michallet M., Slavin S., Frassoni F., Niederwieser D.",00064971,"Blood",96, 11,13,0,0,0,0,13
2000,"Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic lymphocytic leukemia (CLL): Results and prognostic factors for survival after transplantation. Analysis from ebmt registry","Michallet M., Brand R., Dreger P., Millighan D., Esteve J., Kimby E., Apperley J., Van Biezen A., Niederwieser D.",00064971,"Blood",96, 11,6,1,0,1,0,7
2000,"The importance of patient selection in nonmyeloablative stem cell transplant (NMSCT) for acute and chronic leukaemia, myelodysplastic syndrome, and myeloma","Lalancette M., Niederwieser D., Frassoni F., Gahrton G., Apperley J., Michailet M., Szydlo R., Rezvani K., Mackinnon S., Biaise D., Finke J., Slavin S., Alessandrino E.P.",00064971,"Blood",96, 11,3,0,0,0,0,3
2000,"RT-PCR studies in patients with chronic myeloid leukemia (CML) in remission 5 years after allogeneic stem cell transplant (SCT) define risk of subsequent relapse","Mughal T.I., Yong A., Szydlo R.M., Kaeda J., Cross N.C.P., Craddock C., Kanfer E., Apperley J.F., Goldman J.M.",00064971,"Blood",96, 11,1,0,0,0,0,1
2000,"Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen","Craddock C., Lawler M., Goldman J., Hughes T., Derigs G., Bardy P., Kreiter S., Johnston R., Apperley J., Marks D., Huber C., Kolbe K., Goulding R.",00071048,"British Journal of Haematology",111, 3,18,1,0,1,0,19
2000,"A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation","Olavarria E., Goldman J., Hassan M., Eades A., Nilsson C., Timms A., Matthews J., Craddock C., Kanfer E., Apperley J.",08876924,"Leukemia",14, 11,17,3,2,5,0,22
2000,"Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondry acute myeloid leukaemias: A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","De Witte T., Runde V., Niederwieser D., Van Biezen A., Devergie A., Cornelissen J., Jouet J.-P., Arnold R., Apperley J., Hermans J., Vossen J., Bacigalupo A., Meloni G., Jacobsen N., Ruutu T., Ljungman P., Gratwohl A.",00071048,"British Journal of Haematology",110, 3,88,10,9,19,10,117
2000,"Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","Dazzi F., Apperley J.F., Goldman J.M., Szydlo R.M., Cross N.C.P., Craddock C.Charles, Kaeda J., Kanfer E., Cwynarski K., Olavarria E., Yong A.",00064971,"Blood",96, 8,92,16,7,23,3,118
2000,"Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.","Gratwohl A., van Biezen A., Hermans J., Apperley J.",10838791,"Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation",6, 2 A,2,0,0,0,0,2
2000,"Absence of in vitro or in vivo bystander effects in a thymidine kinase- transduced murine T lymphoma","Rivas C., Chandler P., Melo J.V., Simpson E., Apperley J.F.",09291903,"Cancer Gene Therapy",7, 6,4,0,0,0,0,4
2000,"Estimating leukemia-free survival after allografting for chronic myeloid leukemia: A new method that takes into account patients who relapse and are restored to complete remission","Craddock C., Goldman J.M., Szydlo R.M., Klein J.P., Dazzi F., Olavarria E., Van Rhee F., Pocock C., Cwynarski K., Apperley J.F.",00064971,"Blood",96, 1,27,5,2,7,3,37
2000,"Collection of Ph-negative progenitor cells from interferon-responsive patients with chronic myeloid leukemia: Effect of granulocyte-colony- stimulating factor mobilization","Olavarria E., Parker S., Craddock C., Philpott N., Tiniakou M., Chase A., Kanfer E., Apperley J.F., Goldman J.M.",03906078,"Haematologica",85, 6,3,1,0,1,0,4
2000,"Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: An EBMT retrospective analysis","Guglielmi C., Goldman J., Gratwohl A., Kolb H.-J., Iori A.P., Niederwieser D., Prentice H.G., De Witte T., Apperley J., Arcese W., Hermans J., Bacigalupo A., Bandini G., Bunjes D., Carreras E., Devergie A., Frassoni F.",00064971,"Blood",95, 11,15,0,1,1,0,16
2000,"High-dose busulphan alone as cytoreduction before allogeneic or autologous stem cell transplantation for chronic myeloid leukaemia: A single- centre experience","Olavarria E., Kanfer E., Szydlo R., O'Brien S., Craddock C., Apperley J., Goldman J.",00071048,"British Journal of Haematology",108, 4,9,1,0,1,1,11
2000,"HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML)","Posthuma E.F.M., Willemze R., Roosnek E., Niederwieser D., Falkenburg J.H.F., Apperley J.F., Gratwohl A., Hertenstein B., Schipper R.F., Oudshoorn M., V. Biezen J.H., Hermans J.",08876924,"Leukemia",14, 5,11,5,0,5,3,19
2000,"Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): A report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)","Michallet M., Belhabri A., Tanguy M.L., Apperley J.F., Thiebaut A., Dreger P., Remes K., Milpied N., Santini G., Hamon M., Bjorkstrand B., Kimby E.",00071048,"British Journal of Haematology",108, 3,46,5,2,7,2,55
2000,"Ex vivo expansion and characterisation of CD34+ cells derived from chronic myeloid leukaemia bone marrow and peripheral blood, and from normal bone marrow and mobilised peripheral blood","Garin M.I., Apperley J.F., Melo J.V.",09024441,"European Journal of Haematology",64, 2,4,0,0,0,0,4
2000,"Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts","Karadag A., Oyajobi B.O., Apperley J.F., Graham R., Russell G., Croucher P.I.",00071048,"British Journal of Haematology",108, 2,16,3,1,4,1,21
2000,"Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line","Garrett E., Miller A.R.-M., Goldman J.M., Apperley J.F., Melo J.V.",00426822,"Virology",266, 1,9,1,0,1,0,10
2000,"Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia","Dazzi F., Apperley J.F., Goldman J.M., Szydlo R.M., Craddock C., Cross N.C.P., Kaeda J., Chase A., Olavarria E., Van Rhee F., Kanfer E.",00064971,"Blood",95, 1,130,9,14,23,2,155
1999,"Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH-296","Garrett E., Garin M.I., Miller A.R.-M., Goldman J.M., Melo J.V., Apperley J.F.",00071048,"British Journal of Haematology",107, 2,1,0,1,1,0,2
1999,"Malignant neoplasms in long-term survivors of bone marrow transplantation","Kolb H.J., Van Weel M., Wick R., Weiss M., Prentice H.G., Socie G., Duell T., Van Lint M.T., Tichelli A., Apperley J.F., Nekolla E., Ljungman P., Jacobsen N.",00034819,"Annals of Internal Medicine",131, 10,49,9,10,19,8,76
1999,"Syngeneic transplantation in multiple myeloma - A case-matched comparison with autologous and allogeneic transplantation","Gahrton G., Gratwohl A., Guilhot F., Lambertenghi Deliliers G., Ljungman P., Masszi T., Milligan D.W., Powles R.L., Reiffers J., Samson J.D., Stoppa A.M., Svensson H., Vernant J.P., Volin L., Wallvik J., Bjorkstrand B., Apperley J., Carlson K., Cavo M., Ferrant A., Fouillard L., Gratecos N.",02683369,"Bone Marrow Transplantation",24, 7,38,5,2,7,2,47
1999,"Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia","Gooding R.P., Bybee A., Cooke F., Little A., Marsh S.G.E., Coelho E., Gupta D., Samson D., Apperley J.F.",00071048,"British Journal of Haematology",106, 3,17,3,2,5,1,23
1999,"Late effects of transplantation [10]","McCann S., Apperley J., Cohen A., Kolb H.-J., Socie G.",01406736,"Lancet",354, 9180,2,0,0,0,0,2
1999,"Chronic myeloid leukemia in first chronic phase not responding to ?-interferon: Outcome and prognostic factors after antologous transplantation","Boiron J.-M., Cahn J.-Y., Meloni G., Carlo-Stella C., Bandini G., Reman O., Milpied N., Apperley J., Reiffers J.",02683369,"Bone Marrow Transplantation",24, 3,4,1,0,1,0,5
1999,"Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT late-effects working party retrospective data","Cohen A., Kolb H.J., Duell T., Socie G., Van Lint M., Weiss M., Tichelli A., Rovelli A., Apperley J.F., Ljungman P.",02683369,"Bone Marrow Transplantation",23, 10,8,1,0,1,1,10
1999,"HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia","Posthuma E.F.M., Oudshoorn M., Biezen J.H.V., Hermans J., Willemze R., Niederwieser D., Falkenburg J.H.F., Apperley J.F., Gratwohl A., Roosnek E., Hertenstein B., Schipper R.F., Schreuder G.M.T., D'Amaro J.",00064971,"Blood",93, 11,33,5,3,8,4,45
1999,"Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)","Child F.J., Ratnavel R., Watkins P., Samson D., Apperley J., Ball J., Taylor P., Russell-Jones R.",02683369,"Bone Marrow Transplantation",23, 9,51,8,8,16,2,69
1999,"Use of quantitative ASO-PCR to predict relapse in multiple myeloma [6]","Cooke F., Bakkus M., Thielemans K., Pico J.L., Apperley J.F., Samson D.",00071048,"British Journal of Haematology",105, 1,5,0,0,0,0,5
1999,"A comparison of prophylactic vs pre-emptive ganciclovir to prevent cytomegalovirus disease after T-depleted volunteer unrelated donor bone marrow transplantation","Stocchi R., Szydlo R., Craddock C., Kanfer E., Apperley J.F., Goldman J.M., Ward K.N.",02683369,"Bone Marrow Transplantation",23, 7,13,0,0,0,0,13
1999,"Bisphosphonates in multiple myeloma","Apperley J.F., Croucher P.I.",03698114,"Pathologie Biologie",47, 2,2,1,0,1,0,3
1999,"Expression of interleukin-1? and tumour necrosis factor-? in plasma cells from patients with multiple myeloma","Sati H.I.A., Greaves M., Apperley J.F., Russell R.G.G., Croucher P.I.",00071048,"British Journal of Haematology",104, 2,36,4,2,6,0,42
1999,"CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: Tumour cell contamination and outcome","Gupta D., Kanfer E.J., Apperley J.F., Samson D., Bybee A., Cooke F., Giles C., Davis J.G., McDonald C., Armitage S.E., McGuigan D., Lyttelton M.P.A.",00071048,"British Journal of Haematology",104, 1,28,2,1,3,0,31
1999,"Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation","Stocchi R., Ward K.N., Fanin R., Baccarani M., Apperley J.F.",03906078,"Haematologica",84, 1,23,3,5,8,0,31
1998,"Anti-tumour activity of bisphosphonates in human myeloma cells","Shipman C.M., Rogers M.J., Apperley J.F., Russell R.G.G., Croucher P.I.",10428194,"Leukemia and Lymphoma",32, 1-2,14,2,0,2,3,19
1998,"Bone disease in multiple myeloma","Croucher P.I., Apperley J.F.",00071048,"British Journal of Haematology",103, 4,36,4,0,4,1,41
1998,"CD34- selected peripheral blood progenitor cell transplantation and minimal residual disease post-transplant","Apperley J.F., Samson D.",10640525,"Cancer Research Therapy and Control",6, 1-4,0,0,0,0,0,0
1998,"Allogeneic bone marrow transplantation in multiple myeloma - An update of the EBMT registry","Gahrton G., Hagenbeek A., De Laurenzi A., Van Lint M., Michallet M., Nikoskelainen J., Reiffers J., Samson D., Schattenberg A., Verdonck L., Volin L., Tura S., Apperley J., Svensson H., Ljungman P., Blade J., Bjorkstrand B., Cavo M., Facon T., Gratwohl A.",10640525,"Cancer Research Therapy and Control",6, 1-4,0,0,0,0,0,0
1998,"Hematopoietic stem cell transplantation in chronic myeloid leukemia","Apperley J.F.",10656251,"Current Opinion in Hematology",5, 6,6,0,0,0,0,6
1998,"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European group for blood and marrow transplantation","Carreras E., De la Rubia J., Di Girolamo G., Demuynck H., Hartmann O., Clausen J., Ruutu T., Leblond V., Iriondo A., Bosi A., Ben-Bassat I., Bertz H., Koza V., Gratwohl A., Apperley J.F., Arcese W., Vernant J.-P., Tomas J.-F., Hagglund H., Bandini G., Esperou H., Russell J.",00064971,"Blood",92, 10,100,11,18,29,2,131
1998,"Guidelines for the clinical use of blood cell separators","Duguid J.K.M., Bruce M., Chapman J., Knowles S.M., Murphy M.F., Williamson L.M., Wood J.K., Davies J.M., Apperley J.F., Gauly P.S., Gozzard D., Gesinde M.O., Kinsey S., Green R.H.A., Kinsey S.E., Oscier D.G., Potock D., Russell N.H., Smith J.G., Kelsey P.R.",01419854,"Clinical and Laboratory Haematology",20, 5,2,0,0,0,0,2
1998,"How should corticosteroids be used in the treatment of acute GVHD? [2]","Ruutu T., Hermans J., Van Biezen A., Niederwieser D., Gratwohl A., Apperley J.F.",02683369,"Bone Marrow Transplantation",22, 6,5,2,2,4,2,11
1998,"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation","Blade J., Vesole D., Samson D., Reece D., Apperley J., Bjorkstrand B., Gahrton G., Gertz M., Giralt S., Jagannath S.",00071048,"British Journal of Haematology",102, 5,406,116,105,221,43,670
1998,"Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation","Gratwohl A., Niederwieser D., Ruutu T., Vernant J.P., De Witte T., Apperley J., Hermans J., Goldman J.M., Arcese W., Carreras E., Devergie A., Frassoni F., Gahrton G., Kolb H.J.",01406736,"Lancet",352, 9134,221,33,27,60,8,289
1998,"Immunotherapy for chronic myeloid leukaemia","Apperley J.F., Dazzi F., Craddock C., Goldman J.M.",12693286,"Hematology and Cell Therapy",40, 5,4,0,0,0,0,4
1998,"High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: Efficacy and toxicity at three dose levels","Kanfer E.J., MacDonald C., Macdonald D., Olavarria E., Philpott N., Rustin G.J.S., Seckl M.J., Sekhar M., Stern S., Newlands E.S., McGuigan D., Samson D., Abboudi Z., Abrahamson G., Apperley J.F., Chilcott S., Craddock C., Davis J.",00070920,"British Journal of Cancer",78, 7,13,4,0,4,2,19
1998,"Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: An EBMT survey","Arnold R., De Witte T., Van Biezen A., Hermans J., Jacobsen N., Runde V., Gratwohl A., Apperley J.F.",02683369,"Bone Marrow Transplantation",21, 12,60,6,2,8,2,70
1998,"Interleukin-6 is expressed by plasma cells from patients with multiple myeloma and monoclonal gammopathy of undetermined significance","Sati H.I.A., Apperley J.F., Greaves M., Lawry J., Gooding R., Russell R.G.G., Croucher P.I.",00071048,"British Journal of Haematology",101, 2,12,2,0,2,1,15
1998,"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation","Schmitz N., Ringden O., Zander A., Apperley J.F., Gorin C., Borkett K., Schwab G., Goebel M., Russell N.H., Gratwohl A., Bacigalupo A., Hasenclever D., Nagler A., Gluckman E., Clark P., Bourquelot P., Greinix H., Frickhofen N.",02683369,"Bone Marrow Transplantation",21, 10,173,3,7,10,0,183
1998,"Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: Equal efficacy of lymphocytes from sibling and matched unrelated donors","Van Rhee F., Apperley J., Szydlo R., Goldman J.M., Savage D., Blackwell J., Orchard K., Dazzi F., Lin F., Chase A., Bungey J., Cross N.C.P.",02683369,"Bone Marrow Transplantation",21, 10,48,1,4,5,0,53
1998,"Acute leukaemia in Jehovah's Witnesses","Cullis J.O., Duncombe A.S., Dudley J.M., Lumley H.S., Apperley J.F., Smith A.G.",00071048,"British Journal of Haematology",100, 4,12,2,2,4,0,16
1998,"Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: Early transplantation is associated with improved outcome","Runde V., Bacigalupo A., Jacobsen N., Ljungman P., Carreras E., Kolb H.J., Aul C., Apperley J., De Witte T., Arnold R., Gratwohl A., Hermans J., Van Biezen A., Niederwieser D., Labopin M., Walter-Noel M.P.",02683369,"Bone Marrow Transplantation",21, 3,87,7,6,13,5,105
1997,"Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS","De Witte T., Apperley J., Gratwohl A., Laporte J.-P., Van Biezen A., Hermans J., Labopin M., Runde V., Or R., Meloni G., Mauri S.B., Carella A.",00064971,"Blood",90, 10,86,6,2,8,0,94
1997,"Bone marrow transplantation for chronic myeloid leukaemia: The effects of differing criteria for defining chronic phase on probabilities of survival and relapse","Savage D.G., Szydlo R.M., Chase A., Apperley J.F., Goldman J.M.",00071048,"British Journal of Haematology",99, 1,35,6,1,7,2,44
1997,"Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors","Pfeiffer S., Gooding R.P., Apperley J.F., Goldschmidt H., Samson D.",00071048,"British Journal of Haematology",98, 4,33,0,1,1,0,34
1997,"Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation","Van Rhee F., Jacobsen N., Gahrton G., Bandini G., Carreras E., Bacigalupo A., Michallet M., Ruutu T., Reiffers J., Goldman J.M., Apperley J., Szydlo R.M., Hermans J., Devergie A., Frassoni F., Arcese W., De Witte T., Kolb H.J., Niederwiser D.",02683369,"Bone Marrow Transplantation",20, 7,91,4,7,11,0,102
1997,"Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity","Shipman C.M., Rogers M.J., Apperley J.F., Russell R.G.G., Croucher P.I.",00071048,"British Journal of Haematology",98, 3,215,26,13,39,1,255
1997,"Ex vivo generation and function of dendritic cells in multiple myeloma","Pfeiffer S., Samson D., Apperley J., Gooding R.",03005127,"Biochemical Society Transactions",25, 2,2,0,0,0,0,2
1997,"New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia","Carella A.M., Reiffers J., Lerma E., Goldman J., Frassoni F., Melo J., Sawyers C., Eaves C., Eaves A., Apperley J., Tura S., Hehlmann R.",03906078,"Haematologica",82, 4,37,0,0,0,1,38
1997,"European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching","Devergie A., Herstenstein B., Bacigalupo A., Evensen S.A., Ljungman P., De Witte T., Reiffers J., Nagler A., Clark R.E., Goldman J.M., Gratwohl A., Apperley J.F., Labopin M., Madrigal A., Jacobsen N., Carreras E., Prentice H.G., Jouet J.P., Kolb H.J.",02683369,"Bone Marrow Transplantation",20, 1,50,1,2,3,0,53
1997,"Persistence of antibody to human parvovirus B19 after allogeneic bone marrow transplantation: Role of prior recipient immunity","Ang H.A., Apperley J.F., Ward K.N.",00064971,"Blood",89, 12,13,1,2,3,0,16
1997,"Biological properties of peripheral blood progenitor cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor","Scott M.A., Apperley J.F., Bloxham D.M., Jestice H.K., John S., Marcus R.E., Gordon M.Y.",00071048,"British Journal of Haematology",97, 2,7,1,0,1,1,9
1997,"Haploidentical family member transplants for patients with chronic myeloid leukaemia: A report of the Chronic Leukaemia Working Party of the Eeuropean Group for Blood and Marrow Transplantation (EBMT)","Speiser D.E., Hermans J., Van Biezen A., Starobinski M., Jeannet M., Jacobsen N., Niederwieser D., Gratwohl A., Apperley J.F.",02683369,"Bone Marrow Transplantation",19, 12,14,0,2,2,0,16
1997,"A survey of the prophylaxis and treatment of acute GVHD in Europe: A report of the European Group for Blood and Marrow Transplantation (EBMT)","Ruutu T., Niederwieser D., Gratwohl A., Apperley J.F.",02683369,"Bone Marrow Transplantation",19, 8,42,6,8,14,7,63
1997,"Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant","Chen F.E., Owen I., Savage D., Roberts I., Apperley J., Goldman J.M., Laffan M.",02683369,"Bone Marrow Transplantation",19, 5,28,4,6,10,0,38
1997,"Health and functional status of long-term survivors of bone marrow transplantation","Duell T., Kolb H.-J., Van Lint M.T., Ljungman P., Tichclli A., Sode G., Apperley J.F., Weiss M., Cohen A., Nekolla E.",00034819,"Annals of Internal Medicine",126, 3,70,7,10,17,3,90
1997,"Paranasal sinusitis following allogeneic bone marrow transplant","Savage D.G., Taylor P., Blackwell J., Chen F., Szydlo R.M., Rule S.A.J., Spencer A., Apperley J.F., Goldman J.M.",02683369,"Bone Marrow Transplantation",19, 1,18,3,1,4,0,22
1996,"Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: A retrospective case-matched study from the European Group for Blood and Marrow Transplantation","Bjorkstrand B., Ferrant A., Goldstone A.H., De Laurenzi A., Majolino I., Marcus R., Prentice H.G., Remes K., Samson D., Sureda A., Verdonck L.F., Ljungman P., Volin L., Gahrton G., Svensson H., Hermans J., Alegre A., Apperley J., Blade J., Carlson K., Cavo M.",00064971,"Blood",88, 12,218,14,8,22,5,245
1996,"The highest leukaemia-free survival after allogeneic bone marrow Transplantation is seen in patients with grade I acute graft-versus-host disease","Ringden O., Hermans J., Labopin M., Apperley J., Gorin N.C., Gratwohl A.",10428194,"Leukemia and Lymphoma",24, 1-2,51,5,4,9,4,64
1996,"Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia","Gratwohl A., Iriondo A., Kolb H.J., Link H., Niederwieser D., Ruutu T., Schattenberg A., Schmitz N., Siegert W., Torres-Gomez A., Vernant J.P., Hermans J., Zwaan F.E., Apperley J., Biezen A.V., Arcese W., Debusscher L., Ernst P., Ferrant A., Frassoni F., Gahrton G.",00071048,"British Journal of Haematology",95, 3,7,0,0,0,0,7
1996,"The European Group for Blood and Marrow Transplantation (EBMT): A report from the president and the chairmen of the working parties","Gratwohl A., Kolb H.-J., Niethammer D., Gorin C., Apperley J., Goldstone A., Rosti G., Bacigalupo A., Gluckman E., Fischer A., Ljungmang P.",02683369,"Bone Marrow Transplantation",18, 4,5,0,0,0,0,5
1996,"Biochemical bone markers in patients with multiple myeloma","Nawawi H., Samson D., Apperley J., Girgis S.",00098981,"Clinica Chimica Acta",253, 1-2,22,0,0,0,0,22
1996,"Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemia","Rule S.A.J., Miller E., Cranfield T., Apperley J.F., Goldman J.M., Savage D.G., O'Brien S.G., Orchard K., Mcdonald C., Davidson J., Matthey F., Reilly J.T., Bardhan G.",00071048,"British Journal of Haematology",94, 4,5,0,0,0,0,5
1996,"Cloning of a novel membrane-linked metalloproteinase from human myeloma cells","McKie N., Dallas D.J., Edwards T., Apperley J.F., Russell R.G.G., Croucher P.I.",02646021,"Biochemical Journal",318, 2,16,0,0,0,0,16
1995,"Plastic-adherent progenitor cells in mobilized peripheral blood progenitor cell collections","Scott M.A., Apperley J.F., Jestice H.K., Bloxham D.M., Marcus R.E., Gordon M.Y.",00064971,"Blood",86, 12,6,0,0,0,0,6
1995,"Bone marrow transplantation. Review articles must accurately reflect current practice.","Rule S.A., O'Brien S.G., Spencer A., Apperley J., Goldman J.M.",09598138,"BMJ (Clinical research ed.)",310, 6983,0,0,0,0,0,0
1995,"Acute graft-versus-host disease: Grade and outcome in patients with chronic myelogenous leukemia","Gratwohl A., Carreras E., Devergie A., Ferrant A., Fibbe W.E., Frassoni F., Gahrton G., Goldman J., Iriondo A., Jacobsen N., Kolb H.J., Hermans J., Apperley J., Arcese W., Bacigalupo A., Bandini G., Di Bartolomeo P., Boogaerts M., Bosi A.",00064971,"Blood",86, 2,76,6,5,11,2,89
1995,"Peripheral blood progenitor cell harvesting in multiple myeloma and malignant lymphoma","Scott M.A., Ager S., Apperley J.F., Jestice H.K., Bloxham D.M., Boraks P., Mahendra P., Marcus R.E.",10428194,"Leukemia and Lymphoma",19, 5-6,10,1,0,1,1,12
1995,"Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy","Apperley J.F., Reddy N.",0268960X,"Blood Reviews",9, 2,87,4,8,12,7,106
1994,"Autologous transplantation in chronic myelogenous leukemia: European results","Reiffers J., Goldman J., Meloni G., Cahn J.Y., Faberes C., Apperley J.",02683369,"Bone Marrow Transplantation",14, 3,10,0,0,0,0,10
1994,"Interleukin-1?-modulated gene expression in immortalized human chondrocytes","Goldring M.B., Birkhead J.R., Suen L.-F., Yamin R., Mizuno S., Glowacki J., Arbiser J.L., Apperley J.F.",00219738,"Journal of Clinical Investigation",94, 6,169,11,14,25,3,197
1994,"Umbilical cord blood progenitor cell transplantation","Apperley J.F.",02683369,"Bone Marrow Transplantation",14, 2,44,1,1,2,0,46
1994,"Molecular detection of clonally rearranged cells in peripheral blood progenitor cell harvests from multiple myeloma patients","Bird J.M., Bloxham D., Samson D., Marcus R.E., Russell N.H., Kelsey S.M., Newland A.C., Apperley J.F.",00071048,"British Journal of Haematology",88, 1,57,1,0,1,0,58
1994,"Successful pregnancy after allogeneic bone marrow transplantation for chronic myeloid leukaemia [19]","Atkinson H.G., Apperley J.F., Dawson K., Goldman J.M., Winston R.M.L.",01406736,"Lancet",344, 8916,28,0,2,2,0,30
1994,"In vitro proliferation by cells mobilized into the peripheral blood for collection and antologous transplantation","Healy L.E., Nirsimloo N., Scott M., Apperley J.F., Gordon M.Y.",0301472X,"Experimental Hematology",22, 13,9,0,1,1,0,10
1993,"Bone marrow transplantation for chronic myeloid leukemia: Long-term results","Gratwohl A., Bosi A., De Witte T., Fibbe W.E., Zwaan F., Michallet M., Ruutu T., Devergie A., Iriondo A., Apperley J., Reiffers J., Hermans J., Niederwieser D., Frassoni F., Arcese W., Gahrton G., Bandini G., Carreras E., Vernant J.P.",02683369,"Bone Marrow Transplantation",12, 5,122,6,2,8,1,131
1993,"Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia","Arcese W., Ljungman P., Ferrant A., Marosi C., Sayer H., Niederwieser D., Arnold R., Bandini G., Carreras E., Parker A., Frappaz D., Goldman J.M., D'Arcangelo E., Schattenberg A., Nardi A., Apperley J.F., Frassoni F., Aversa F., Prentice H.G.",00064971,"Blood",82, 10,80,0,0,0,0,80
1993,"Bone marrow transplant for the haemoglobinopathies: Past, present and future","Apperley J.F.",09503536,"Bailliere's Clinical Haematology",6, 1,10,0,0,0,0,10
1992,"Circulating stem cells in mice treated with cyclophosphamide","Craddock C.F., Apperley J.F., Wright E.G., Healy L.E., Bennett C.A., Evans M., Grimsley P.G., Gordon M.Y.",00064971,"Blood",80, 1,16,0,1,1,0,17
1992,"Successful use of liposome encapsulated amphotericin to treat invasive aspergillosis following failure of conventional amphotericin","Richards E.M., Apperley J.F., Marcus R.E.",01419854,"Clinical and Laboratory Haematology",14, 2,1,0,0,0,0,1
1992,"HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Influence of GVHD prophylaxis on outcome","Marks D.I., Hows J.M., Goldman J.M., Hughes T.P., Szydlo R., Kelly S., Cullis J.O., Schwarer A.P., Mackinnon S., Apperley J., Barrett A.J.",00071048,"British Journal of Haematology",81, 3,24,0,0,0,0,24
1991,"Retroviral-mediated gene transfer of human adenosine deaminase into murine hematopoietic cells","Apperley J.F., Luskey B.D., Williams D.A.",00371963,"Seminars in Hematology",28, 2,2,0,0,0,0,2
1991,"Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: Effect of selectable marker sequences on long-term expression","Apperley J.F., Luskey B.D., Williams D.A.",00064971,"Blood",78, 2,44,1,0,1,1,46
1990,"Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells","Luskey B.D., Lim B., Apperley J.F., Orkin S.H., Williams D.A.",00778923,"Annals of the New York Academy of Sciences",612, ,2,1,0,1,0,3
1990,"Bone marrow transplantation for chronic myeloid leukemia: The use of histocompatible unrelated volunteer donors","Mackinnon S., Catovsky D., Galton D.A.G., Bidwell J., Bradley B., Cleaver S., Hale G., Waldman H., Hows J.M., Goldman J.M., Arthur C.K., Hughes T., Apperley J.F., Jones L., Batchelor J.R., Brookes P.",0301472X,"Experimental Hematology",18, 5,24,0,0,0,0,24
1990,"Gene therapy: Current status and future directions","Apperley J.F., Williams D.A.",00071048,"British Journal of Haematology",75, 2,6,0,0,0,0,6
1989,"Long-term expression of human adenosine deaminase in mice transplanted with retrovirus-infected hematopoietic stem cells","Lim B., Apperley J.F., Orkin S.H., Williams D.A.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",86, 22,44,0,0,0,0,44
1989,"Slow evolution of chronic myeloid leukaemia relapsing after BMT with T-cell depleted donor marrow","Hughes T.P., Goldman J.M., Economou K., Mackinnon S., Vlitos M., Arthur C.K., Guo A.P., Rassool F., Apperley J.F., Hows J.",00071048,"British Journal of Haematology",73, 4,15,0,0,0,0,15
1989,"Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis","Brito-Babapulle F., Galton D.A.G., McCarthy D., Goldman J.M., Bowcock S.J., Marcus R.E., Apperley J., Th'ng K.H., Dowding C., Rassool F., Guo A.-P., Catovsky D.",00071048,"British Journal of Haematology",73, 1,35,1,0,1,0,36
1989,"The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells","Apperley J.F., Dowding C., Hibbin J., Buiter J., Matutes E., Sissons P.J., Gordon M., Goldman J.M.",0301472X,"Experimental Hematology",17, 1,42,1,2,3,1,46
1989,"Total lymphoid irradiation preceding bone marrow transplantation for chronic myeloid leukaemia","James N.D., Apperley J.F., Kam K.C., Mackinnon S., Goldman J.M., Goolden A.W.G., Sikora K.",00099260,"Clinical Radiology",40, 2,0,0,0,0,0,0
1988,"Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Importance of a graft-versus-leukaemia effect","Apperley J.F., Wardle D., Gravett P., Franklin I.M., Bandini G., Ricci P., Tura S., Iacone A., Torlontano G., Heit W., Champlin R., Mauro F.R., Gale R.P., Goldman J.M., Gregory W., Arthur C.K., Hows J., Arcese W., Papa G., Mandelli F.",00071048,"British Journal of Haematology",69, 2,78,3,3,6,1,85
1988,"Use of minisatellite DNA probes for recognition and characterization of relapse after allogenic bone marrow transplantation","Min G.L., Hibbin J., Arthur C., Apperley J., Jeffreys A., Goldman J.",00071048,"British Journal of Haematology",68, 2,12,1,0,1,0,13
1988,"Cytomegalovirus: Biology, clinical features and methods for diagnosis","Apperley J.F., Goldman J.M.",02683369,"Bone Marrow Transplantation",3, 4,24,2,0,2,0,26
1988,"Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase","Arthur C.K., Apperley J.F., Guo A.P., Rassool F., Gao L.M., Goldman J.M.",00064971,"Blood",71, 5,20,1,0,1,0,21
1988,"Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia","Sutedja T.G., Apperley J.F., Hughes J.M.B., Aber V.R., Kennedy H.G., Nunn P., Jones L., Hopper L., Goldman J.M.",00406376,"Thorax",43, 3,12,1,1,2,1,15
1987,"Complete remission after autografting for chronic myeloid leukaemia","Brito-Babapulle F., Apperley J.F., Rassool F., Guo A.-P., Dowding C., Goldman J.M.",01452126,"Leukemia Research",11, 12,7,0,0,0,0,7
1987,"Identical twin marrow transplantation for 5 patients with chronic myeloid leukaemia: Role of DNA finger-printing to confirm monozygosity in 3 cases","Jones L., Thein S.L., Jeffreys A.J., Apperley J.F., Catovsky D., Goldman J.M.",09024441,"European Journal of Haematology",39, 2,2,0,0,0,0,2
1987,"HIV infection due to a platelet transfusion after allogeneic bone marrow transplantation.","Apperley J.F., Rice S.J., Hewitt P., Rombos Y., Barbara J., Gabriel F.G., Goldman J.M.",09024441,"European journal of haematology",39, 2,0,1,0,1,2,3
1987,"Antibody titres to a rough-mutant strain of Escherichia coli in patients undergoing allogeneic bone-marrow transplantation. Evidence of a protective effect against graft-versus-host disease.","Cohen J., Moore R.H., Al Hashimi S., Jones L., Apperley J.F., Aber V.R.",01406736,"Lancet",1, 8523,2,0,0,0,0,2
1987,"Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation","Apperley J.F., Rice S.J., Bishop J.A.",00411337,"Transplantation",43, 1,49,2,4,6,2,57
1987,"Subacute thyroiditis after bone marrow transplant for chronic granulocytic leukaemia","Jones L., Ball J., Apperley J.F.",02683369,"Bone Marrow Transplantation",1, 4,1,0,0,0,0,1
1986,"Philadelphia-positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia","Apperley J.F., Rassool F., Parreira A.",03618609,"American Journal of Hematology",22, 2,3,0,0,0,0,3
1986,"Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse","Apperley J.F., Jones L., Hale G.",02683369,"Bone Marrow Transplantation",1, 1,103,8,5,13,1,117
1986,"Bone marrow transplantation for patients with chronic myeloid leukemia","Goldman J.M., Apperley J.F., Jones L.",00284793,"New England Journal of Medicine",314, 4,132,3,5,8,2,142
1985,"BK virus as cause of haemorrhagic cystitis after bone marrow transplantation","Rice S.J., Bishop J.A., Apperley J., Gardner S.D.",01406736,"Lancet",2, 8459,11,2,0,2,1,14
1985,"Adult respiratory distress syndrome after allogeneic bone-marrow transplantation: Evidence for a neutrophil-independent mechanism","Braude S., Apperley J., Krausz T.",01406736,"Lancet",1, 8440,18,0,1,1,1,20
1985,"Bone marrow transplantation for chronic myeloid leukemia","Apperley J.F., Goldman J.M.",02786222,"Plasma Therapy and Transfusion Technology",6, 2,0,0,0,0,0,0
1985,"Foscarnet for cytomegalovirus pneumonitis","Apperley J.F., Marcus R.E., Goldman J.M.",01406736,"Lancet",1, 8438,1,0,0,0,0,1
1984,"Non-cardiotoxic anthracycline regimens in the treatment of acute myeloblastic leukaemia","Boughton B.J., Franklin I.M., Apperley J., Knight D.",00071048,"British Journal of Haematology",58, 2,1,0,0,0,0,1
